menu
    • menu

    Company profile for Armatus Bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Armatus Bio is a biotechnology company pioneering novel genetic medicines to treat rare neurological and neuromuscular disorders. We combine cutting-edge science with targeted delivery platforms to develop transformative therapies for patients with high unmet needs. Our team of experts is dedicated to advancing innovative treatments from discovery to clinical development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Armatus BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1275 Kinnear Road, Columbus, OH 43212
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://armatusbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/armatusbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Armatus Bio Finalist for XPRIZE Healthspan FSHD Bonus Prize
    Armatus Bio Finalist for XPRIZE Healthspan FSHD Bonus Prize

    12 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250512921811/en/Armatus-Bio-Selected-as-Finalist-for-XPRIZE-Healthspan-FSHD-Bonus-Prize

    BUSINESSWIRE
    12 May 2025
    Share Share
    Solve FSHD invests $3M in Armatus Bio for FSHD Gene Therapy
    Solve FSHD invests $3M in Armatus Bio for FSHD Gene Therapy

    06 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250506606967/en/SOLVE-FSHD-Announces-%243-Million-Investment-in-Armatus-Bio-to-Advance-Gene-Therapy-Program-for-FSHD

    BUSINESSWIRE
    06 May 2025
    Share Share
    Solid Biosciences Announces Licensing Agreement with Armatus Bio
    Solid Biosciences Announces Licensing Agreement with Armatus Bio

    07 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/07/2842105/0/en/Solid-Biosciences-Announces-Licensing-Agreement-with-Armatus-Bio-for-the-Use-of-AAV-SLB101-a-Proprietary-Muscle-Targeted-Capsid-in-the-Development-of-an-RNAi-Therapy-to-treat-FSHD.html

    GLOBENEWSWIRE
    07 Mar 2024
    Share Share
    Andelyn Biosciences & Armatus Partner to Manufacture AAV Gene
    Andelyn Biosciences & Armatus Partner to Manufacture AAV Gene

    15 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/andelyn-biosciences-and-armatus-bio-partner-to-manufacture-suspension-based-aav-gene-therapy-for-rare-neurological-disease-charcot-marie-tooth-type-1a-cmt1a-302034766.html

    PR NEWSWIRE
    15 Jan 2024
    Share Share
    CMTA Announces Participation in Seed Extension for Armatus Bio
    CMTA Announces Participation in Seed Extension for Armatus Bio

    16 Nov 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=804262&lang=en

    ACCESSWIRE
    16 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search